S-1 combined with weekly paclitaxel in patients with advanced gastric cancer

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 33 Suppl 1, Issue , 2006, Pages 91-94

  Gotoh, Masahiro ^a   Kawabe, Shin ichiro ^a   Takiuchi, Hiroya ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; OXONIC ACID; PACLITAXEL; S 1 (COMBINATION); TEGAFUR;

ANEMIA; ANOREXIA; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAXIMUM TOLERATED DOSE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW; STOMACH TUMOR;

ADMINISTRATION, ORAL; ANEMIA; ANOREXIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; HUMANS; INFUSIONS, INTRAVENOUS; MAXIMUM TOLERATED DOSE; OXONIC ACID; PACLITAXEL; STOMACH NEOPLASMS; TEGAFUR;

EID: 33747407320     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)